THE SINGLE BEST STRATEGY TO USE FOR MILD COGNITIVE IMPAIRMENT TREATMENT

Prescribing facts for lecanemab features a boxed warning about probable challenges affiliated with ARIA. Appropriate use suggestions explore ways to minimize ARIA risk, as does AAN assistance.The extension research also evaluated CLARITY Advertisement contributors who experienced a delayed get started (those that switched from placebo to lecanemab